No annual revenue total was found in CELCUITY INC.'s SEC filings.
Celcuity Inc. (CELC) files with the SEC under industry code 8071, Services-Medical Laboratories. Free cash flow was -$153.5 million. As of Sep 30, 2026 it held $642.7 million in cash and investments and $1.1 million in total debt.
Revenue
—
Net income (TTM)
$-256.01M
-57.3% vs year-ago TTM
Operating cash flow (TTM)
$-213.12M
-47.3% vs year-ago TTM
Free cash flow (TTM)
$-213.48M
-47.3% vs year-ago TTM
EPS (TTM)
$-4.72
-28.5% vs year-ago TTM
Dividend per share
None
Shares outstanding
48.34M
+27.7% vs prior year
Net cash
$641.60M
as of Sep 30, 2026
Operating margin
—
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- CELC (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Minneapolis, MN
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1603454
- Former names
- Celcuity LLC (until Sep 15, 2017)
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Operating income | -$172.2M | -$113.3M | -$66.2M | -$39.4M | -$28.4M |
| Net income | -$177.0M | -$111.8M | -$63.8M | -$40.4M | -$29.6M |
| Diluted EPS | -$3.79 | -$2.83 | -$2.69 | — | — |
| Operating cash flow | -$153.3M | -$83.5M | -$53.8M | -$36.0M | -$20.3M |
| Free cash flow | -$153.5M | -$83.7M | -$53.9M | -$36.2M | -$20.4M |
| Total assets | $466.6M | $245.1M | $191.2M | $175.7M | $85.9M |
| Total liabilities | $366.0M | $129.5M | $51.5M | $41.9M | $17.2M |
| Stockholders' equity | $100.6M | $115.6M | $139.8M | $133.8M | $68.7M |
| Cash and investments | $441.5M | $235.1M | $180.6M | $168.6M | $84.3M |
| Total debt | $137.6M | $105.3M | $38.0M | $36.0M | $16.2M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 2, 2026 | Oct 1, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 30, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 26, 2026 | Aug 26, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
All 541 Celcuity Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.